ARCHIVES

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

October 13, 2000

Abstracts Deadline For Cancer Congress Extended To Dec. 31

December 13, 1985

NCI Awards $6.7 Million For Breast Cancer Research.

September 8, 2000

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

November 30, 2001